Fig. 5
From: Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study
EQ5D-VAS scores of the women with osteoporosis treated with teriparatide at start and after 10 years (Severe problems, Some problems, No problems) in five different Health-Related Quality of Life (HRQoL) domains (Mobility, Self-care, Usual Activities, Pain/Discomfort, Anxiety/Depression). P-values for comparison between start and after 10 years are reported for each domain, respectively